Drug · DIN 02313898
BENREX
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 4, 2022.
- Drug Identification Number (DIN)
- 02313898
- Company (DIN owner)
- Imrex IncorporatedBurlington, Ontario, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Solution
- Route
- Topical
- Therapeutic class (ATC)
- Benzalkonium D08AJ01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BENZALKONIUM CHLORIDE | 0.15 % | W/W |